Bilateral PVN microinjection of Ad-ACE2 attenuated Angiotensin II-induced hypertension, reducing mean arterial pressure from 162.9 ± 3.6 mmHg to 130.2 ± 5.7 mmHg at 14 days.
Absolute Event Rate: 130.2% vs 162.9%
AIMS: Angiotensin II (Ang II) has been shown to have both central and peripheral effects in mediating hypertension, for which the hypothalamic paraventricular nucleus (PVN) is an important brain cardio-regulatory centre. Angiotensin-converting enzyme 2 (ACE2) has been identified as a negative regulator of the pro-hypertensive actions of Ang II. Recent findings from our laboratory suggest that Ang II infusion decreases ACE2 expression in the PVN. In the present study, we hypothesized that ACE2 overexpression in the PVN will have beneficial effects in counteracting Ang II-induced hypertension. METHODS AND RESULTS: Male Sprague-Dawley rats were used in this study. Bilateral microinjection of an adenovirus encoding hACE2 (Ad-ACE2) into the PVN was used to overexpress ACE2 within this region. Mean arterial pressure measured by radiotelemetry was significantly increased after 14 days in Ang II-infused (200 ng/kg/min) rats vs. saline-infused controls (162.9 ± 3.6 vs. 102.3 ± 1.5 mmHg). Bilateral PVN microinjection of Ad-ACE2 attenuated this Ang II-induced hypertension (130.2 ± 5.7 vs. 162.9 ± 3.6 mmHg). ACE2 overexpression also significantly decreased AT(1)R and ACE expression and increased AT(2)R and Mas expression in the PVN. Additionally, ACE2 overexpression in the PVN attenuated the Ang II-induced increase in the expression of the pro-inflammatory cytokines tumour necrosis factor-α, interleukin (IL)-1β and IL-6 in the PVN. CONCLUSION: Our findings suggest that attenuation of pro-inflammatory cytokines in the PVN in combination with the shift of the renin-angiotensin system towards the anti-hypertensive axis (ACE2/Ang-(1-7)/Mas) may be responsible for the overall beneficial effects of ACE2 overexpression in the PVN on the Ang II-induced hypertensive response.
Sriramula et al. (Tue,) conducted a other in Angiotensin II-induced hypertension. Bilateral microinjection of an adenovirus encoding hACE2 (Ad-ACE2) into the PVN vs. Angiotensin II infusion alone was evaluated on Mean arterial pressure. Bilateral PVN microinjection of Ad-ACE2 attenuated Angiotensin II-induced hypertension, reducing mean arterial pressure from 162.9 ± 3.6 mmHg to 130.2 ± 5.7 mmHg at 14 days.